Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Under BioMotiv arrangement, BMS launches Anteros, assigns IP

Executive Summary

Less than a year after Bristol-Myers Squibb Co. became a limited partner in BioMotiv LLC, the companies launched their first venture, Anteros Pharmaceuticals, with assets from BMS.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R+D and Marketing-Licensing
    • Includes M&A Option
    • Reverse Licensing

Related Companies